Featured Research

from universities, journals, and other organizations

Researchers Track Path Of Safer Gene Delivery Method

Date:
May 11, 1999
Source:
Rice University
Summary:
A material used for years in common processes such as shampoo manufacturing, paper production and water filtration may one day bring DNA to a patient's cells by way of a safer, nonviral gene therapy method.

HOUSTON, May 5, 1999 -- A material used for years in common processes such as shampoo manufacturing, paper production and water filtration may one day bring DNA to a patient's cells by way of a safer, nonviral gene therapy method.

Poly(ethylenimine) (PEI), a polymer, has been used to successfully transfer genes into living cells. For the first time, researchers at Rice University and the University of Texas-Houston Health Science Center have tracked the path that this polymer--which acts as an artificial virus--and the DNA it carries take through the cell. They have shown that the complex ends up--intact--in the cell's nucleus, where the new DNA can be read and put to work.

Antonios (Tony) Mikos, Rice professor of bioengineering, W.T. (Terry) Godbey, Rice graduate student in biochemistry and cell biology, and Kenneth Wu, professor and director of the Division of Hematology and Vascular Biology Research Center at the UT-Houston Health Science Center, labeled PEI/DNA complexes, which are joined by their electrostatic attraction to each other, with fluorescent markers and followed the trail as they moved through the cell to the nucleus.

"This study improved our understanding of the transport of DNA into the nucleus and provided new knowledge for the design of better and safer nonviral carriers for gene delivery," Mikos said.

The findings are published in the April 27 issue of the Proceedings of the National Academy of Sciences.

"We ran into something a little bit surprising--that PEI actually delivers the DNA to the nucleus without separating from the DNA--they get in as intact structures," Godbey said. "That's important because there are other polycationic [positively charged] systems that exist and if our carrier gets into the nucleus, other polycationic carriers might also get in." The researchers caution, however, that the effect the PEI has on the cell needs to be known before this method could be used to treat disease.

They found that the PEI/DNA complexes attach to cell membranes and then join into clumps that are taken into the cell. Once inside the cell, rather than being broken down and used by the cell's machinery, the complexes move into the nucleus, where the desired gene is turned on.

The researchers labeled both the DNA and the PEI separately in different colors, to verify that the complex gets into the nucleus intact.

Exactly how the DNA-polymer complex enters cell nuclei is not yet explained, but the researchers suggest the PEI/DNA could become coated with phospholipids, which help regenerate the cell membrane. The coated complexes might fuse with the membrane, and then release the PEI/DNA into the nucleus. More research needs to be done to determine the mechanism.

Gene therapy has traditionally taken advantage of a virus's ability to inject its DNA into cells, but with the viral agents come risks, such as an immune response. Researchers have wanted to find safer, nonviral agents to gain access to cells.

Both viral methods and nonviral methods using liposomes, which can fuse with the cell membrane to gain entry, have been used in clinical trials to treat Cystic Fibrosis and several forms of cancer. "The results that we're getting with the polymer rival if not exceed the results achievable with liposomes," Godbey said.

Said Mikos, "One of the great potentials of this method that uses synthetic polymers is not only that it is much safer than viral systems but one can modify the polymer and incorporate specific ligands so it can deliver the DNA to the desired cell type for targeted gene therapy."

In addition to Cystic Fibrosis and cancer, the technique is also promising for cardiovascular applications such as balloon angioplasty. During the procedure, gene therapy could be used to deliver genes aimed at slowing down the rapid proliferation of cells which causes scarring and a re-narrowing of the artery. It could also be used in growing tissue-engineered bone for repairing bone defects by delivering growth factors that increase the proliferation of cells.

Mikos and Godbey point out that it is a versatile method. With the PEI/DNA complex, they are not limited by the gene or genes that they want to deliver. PEI/DNA can be injected into the patient intravenously; gene therapy with PEI can be done in the lab, such as in growing new bone, and then introduced into the body; and it could be introduced during surgery.

"The ultimate goal of this approach will be to apply it to a clinical situation that will treat a disease or try to repair a defect in a tissue," Mikos said. "However, before we get to that point there are some very basic questions we have to address about the fate of the polymer itself and also in trying to understand the mechanism before this system reaches the clinic," he cautioned.


Story Source:

The above story is based on materials provided by Rice University. Note: Materials may be edited for content and length.


Cite This Page:

Rice University. "Researchers Track Path Of Safer Gene Delivery Method." ScienceDaily. ScienceDaily, 11 May 1999. <www.sciencedaily.com/releases/1999/05/990511075040.htm>.
Rice University. (1999, May 11). Researchers Track Path Of Safer Gene Delivery Method. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/1999/05/990511075040.htm
Rice University. "Researchers Track Path Of Safer Gene Delivery Method." ScienceDaily. www.sciencedaily.com/releases/1999/05/990511075040.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Nigeria Ups Ebola Stakes on 1st Death

Nigeria Ups Ebola Stakes on 1st Death

Reuters - Business Video Online (July 29, 2014) Nigerian authorities have shut and quarantined a Lagos hospital where a Liberian man died of the Ebola virus, the first recorded case of the highly-infectious disease in Africa's most populous economy. David Pollard reports Video provided by Reuters
Powered by NewsLook.com
Running 5 Minutes A Day Might Add Years To Your Life

Running 5 Minutes A Day Might Add Years To Your Life

Newsy (July 29, 2014) According to a new study, just five minutes of running or jogging a day could add years to your life. Video provided by Newsy
Powered by NewsLook.com
Ebola Outbreak Poses Little Threat To U.S.: CDC

Ebola Outbreak Poses Little Threat To U.S.: CDC

Newsy (July 29, 2014) The Ebola outbreak in West Africa poses little threat to Americans, according to officials with the Centers for Disease Control and Prevention. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins